wafergen bio-systems inc (WGBS:OTC US)

Financial Statements for wafergen bio-systems inc (WGBS)

Currency in Millions of US Dollars	As of:	Dec 31 2009 Restated	Dec 31 2010	Dec 31 2011 Restated	Dec 31 2012	4 Year Trend
Revenues		0.4	2.2	0.5	0.6
TOTAL REVENUES		0.4	2.2	0.5	0.6
Cost of Goods Sold		0.3	0.9	1.4	0.4
GROSS PROFIT		0.1	1.3	-0.9	0.2
Selling General & Admin Expenses, Total		5.0	7.2	9.5	3.8
R&D Expenses		5.1	6.7	8.3	6.2
OTHER OPERATING EXPENSES, TOTAL		10.1	13.9	17.8	9.9
OPERATING INCOME		-10.0	-12.6	-18.7	-9.8
Interest Expense		0.0	0.0	-3.3	-2.1
Interest and Investment Income		0.0	0.0	0.0	0.0
NET INTEREST EXPENSE		0.0	0.0	-3.3	-2.1
Currency Exchange Gains (Loss)		-0.1	-0.1	0.2	-0.1
Other Non-Operating Income (Expenses)		--	0.6	9.3	3.8
EBT, EXCLUDING UNUSUAL ITEMS		-10.1	-12.1	-12.6	-8.2
Other Unusual Items, Total		-0.6	--	-0.5	--
Other Unusual Items		-0.6	--	-0.5	--
EBT, INCLUDING UNUSUAL ITEMS		-10.6	-12.1	-13.1	-8.2
Income Tax Expense		--	--	0.0	0.0
Earnings from Continuing Operations		-10.6	-12.1	-13.1	-8.2
NET INCOME		-10.6	-12.1	-13.1	-8.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS		-10.8	-12.8	-22.8	-9.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS		-10.8	-12.8	-22.8	-9.0

Report Data Issue

To contact WAFERGEN BIO-SYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.